日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021

2021年2月至5月,以色列,接种Comirnaty mRNA COVID-19疫苗后137天内SARS-CoV-2刺突蛋白IgG抗体滴度

Patalon, Tal; Ben Moshe, Shay; Peretz, Asaf; Neuberger, Ami; Schreiber, Licita; Lazar, Rachel; Supino-Rosin, Lia; Perez, Galit; Mizrahi-Reuveni, Miri; Gazit, Sivan

Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study

一项前瞻性纵向队列研究显示,免疫功能低下者和健康个体接种第三次BNT162b2疫苗后,抗体反应较第二次接种时更为显著。

Shapiro Ben David, Shirley; Mizrahi, Barak; Rahamim-Cohen, Daniella; Supino-Rosin, Lia; Shahar, Arnon; Hermoni-Alon, Sharon; Fremder Sacerdote, Ariela; Irony, Angela; Lazar, Rachel; Kalkstein, Nir; Lustig, Yaniv; Indenbaum, Victoria; Landsberger, Daniel; Mizrahi-Reuveni, Miri; Shapira, Shirley

Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation.

全国多中心对七种血清学检测方法的比较显示,存在 SARS-CoV-2 无反应血清阴性亚群

Oved Kfir, Olmer Liraz, Shemer-Avni Yonat, Wolf Tamar, Supino-Rosin Lia, Prajgrod George, Shenhar Yotam, Payorsky Irina, Cohen Yuval, Kohn Yishai, Indenbaum Victoria, Lazar Rachel, Geylis Valeria, Oikawa Michal Tepperberg, Shinar Eilat, Stoyanov Evgeniy, Keinan-Boker Lital, Bassal Ravit, Reicher Shay, Yishai Ruti, Bar-Chaim Adina, Doolman Ram, Reiter Yoram, Mendelson Ella, Livneh Zvi, Freedman Laurence S, Lustig Yaniv